Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy

  • Conesa-Bakkali, Ryan
  • Morillo-Huesca, Macarena
  • Martínez-Fábregas, Jonathan
Lysosomes are subcellular compartments characterised by an acidic pH, containing an ample variety of acid hydrolases involved in the recycling of biopolymers. Among these hydrolases, lysosomal proteases have merely been considered as end-destination proteases responsible for the digestion of waste proteins, trafficked to the lysosomal compartment through autophagy and endocytosis. However, recent reports have started to unravel specific roles for these proteases in the regulation of initially unexpected biological processes, both under physiological and pathological conditions. Furthermore, some lysosomal proteases are no longer restricted to the lysosomal compartment, as more novel non-canonical, extralysosomal targets are being identified. Currently, lysosomal proteases are accepted to play key functions in the extracellular milieu, attached to the plasma membrane and even in the cytosolic and nuclear compartments of the cell. Under physiological conditions, lysosomal proteases, through non-canonical, extralysosomal activities, have been linked to cell differentiation, regulation of gene expression, and cell division. Under pathological conditions, these proteases have been linked to cancer, mostly through their extralysosomal activities in the cytosol and nuclei of cells. In this review, we aim to provide a comprehensive summary of our current knowledge about the extralysosomal, non-canonical functions of lysosomal proteases, both under physiological and pathological conditions, with a particular interest in cancer, that could potentially offer new opportunities for clinical intervention., This work was supported by the Consejería de Transformación Económica, Industria, Conocimiento y Universidades under the EMERGIA programme (EMC21_00124) from the Andalusian Regional Government. J.M.-F. was also funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie programme (H2020-MSCA-IF-2020, 101025429), the Spanish Ministry of Science and Innovation under the Ramon y Cajal programme (RYC2021-032389-I) and the VII PPIT of the University of Seville (2023/00000479) granted to J.M.-F., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Radiotherapy resistance driven by Asparagine endopeptidase through ATR pathway modulation in breast cancer

  • Morillo-Huesca, Macarena
  • López-Cepero, Ignacio G.
  • Conesa-Bakkali, Ryan
  • Tomé, Mercedes
  • Watts, Colin
  • Huertas, Pablo
  • Moreno-Bueno, Gema
  • Durán, Raúl V.
  • Martínez-Fábregas, Jonathan
Tumor resistance represents a major challenge in the current oncology landscape. Asparagine endopeptidase (AEP) overexpression correlates with worse prognosis and reduced overall survival in most human solid tumors. However, the underlying mechanisms of the connection between AEP and reduced overall survival in cancer patients remain unclear., Research and publication of this work was funded by the EMERGIA 2021 program (EMERGIA21_00124) from the Consejería de Universidad, Investigación e Innovación, Junta de Andalucía, Spain to J.M-F. J.M-F. was supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie programme (101025429), the Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MICINN-AEI, RYC2021-032389), the Consejería de Universidad, Investigación e Innovación under the EMERGIA program (EMC21_00124) Junta de Andalucia, and the VII PPIT of the University of Seville (2023/00000479). RVD and G.M-B were supported by MICINN-AEI and European Regional Development Fund (project PID2021-124251OB-I00 and PID2022-136854OB-I00, respectively). G.M-B was also funded by The Instituto de Salud Carlos III IISCIII, CIBERONC (CB16/12/00295) and ERA PerMed ERA-NET co-funded by the NextGeneration-EU (ISCIII and Fundacion cientifica AECC, AC21_2/00020). PH was supported by R + D + I grant (PID2019-104195G) from the Spanish Ministry of Science and Innovation-Agencia Estatal de Investigación/10.13039/501100011033. CW was supported by a Welcome Trust Programme Grant., Peer reviewed